Skip to content

Merging News

About
Contact
Home
Home
Privacy Policy

Merging News

LEO Pharma Bolsters Rare Skin Disease Focus Through Acquisition of Replay Gene Therapy Platform – Business Wire

Leave a Comment / Pharma and Biotech / By

LEO Pharma Bolsters Rare Skin Disease Focus Through buyout of Replay Gene Therapy Platform Business Wire

Source: news.google.com

← Previous Post

Related Posts

Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc – PR Newswire

Day One Biopharmaceuticals to Acquire Mersana Therapeutics – GlobeNewswire

Leave a Comment Cancel Reply

Your email address will not be published. Required fields are marked *

Type here..

Name*

Email*

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Search

Recent Posts

Infoblox Completes Axur Acquisition, Expands Preemptive Security to Stop External Threats at the Source – GlobeNewswire
GME Supply Accelerates Strategic Growth with Acquisition of Peak Trading and ASK Tower Supply – PR Newswire
Point C Expands National Footprint With Strategic Acquisition of Coastal Administrative Services – Business Wire
Workplace Catering is a Powerful Acquisition Engine for Restaurants New ezCater Data Reveals – Business Wire
CQ Medical® Enhances Patient-Specific Cancer Treatment Capabilities Through .decimal® Acquisition – PR Newswire

Recent Comments

No comments to show.

Archives

May 2026
April 2026
March 2026
February 2026
January 2026
December 2025
November 2025
October 2025
September 2025
August 2025
July 2025
June 2025
May 2025
April 2025
March 2025

Categories

Bankruptcy
Energy and Materials
Financial Services
Mega Deals
Pharma and Biotech
Tech and Software

About
Contact
Home
Home
Privacy Policy

Sign up to receive email updates, fresh news and more!

There was an error trying to submit your form. Please try again.

This field is required.

There was an error trying to submit your form. Please try again.

Copyright © 2026 Merging News | Powered by Merging News